UNSPSC 51372039: Morphine tartrate

This classification denotes an opioid receptor agonist with the molecular formula 2C17H19NO3.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U3NSU23LHD. European Medicines Agency schedules morphine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14598MIG. The term morphine tartrate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule morphine tartrate under HS 29391100 and SITC 54141.

As of Q4 2014, MORPHINE TARTRATE remains US FDA's Preferred Term for this commodity. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O.CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51372039 Morphine tartrate is a Commodity code that captures pharmaceutical procurement by state and local health and public-safety agencies, though recent solicitation activity under this code shows minimal alignment with the nominal scope. The single recent opportunity in the block — Seminole County, Florida's IFB for naloxone and drug deactivation systems — represents emergency-response and harm-reduction pharmaceuticals rather than morphine tartrate specifically. State and local governments soliciting under pharmaceutical commodity codes typically acquire controlled and non-controlled drugs for public health programs, emergency medical services, corrections, and community health initiatives. The issuing bodies span county health departments, municipal public-safety agencies, and regional health authorities. Procurement vehicles include competitive sealed bids (IFBs) with fixed-fee pricing, multi-year terms with renewal options, and requirements for drug-free workplace certification, E-Verify compliance, workers' compensation, and commercial general liability insurance.

Seminole County, Florida represents the documented geographic activity in the recent-opportunities block. The county's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, with a two-year initial term and one-year renewal option. The procurement required vendors to include all shipping and delivery costs in their bids and submit electronically through the county's e-Procurement Portal. The opportunity included a three-month probationary termination clause and potential FEMA funding with associated federal compliance obligations. The code shows limited recent state and local activity documented in the source; prospectors should monitor county health-department and public-safety RFPs in Florida and adjacent states for broader pharmaceutical procurement patterns beyond this single posting.